Goodwill And Other Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2011

Goodwill And Other Intangible Assets [Abstract]


	Generics Segment			Specialty Segment			Total
(In thousands)
Balance at December 31, 2009
Goodwill	$	3,009,740		$	706,507		$	3,716,247
Accumulated impairment losses		—			(385,000	)		(385,000	)

		3,009,740			321,507			3,331,247
Goodwill acquired⁽¹⁾		212,749			—			212,749
Foreign currency translation and other		55,338			—			55,338

		3,277,827			321,507			3,599,334

Balance at December 31, 2010
Goodwill		3,277,827			706,507			3,984,334
Accumulated impairment losses		—			(385,000	)		(385,000	)

		3,277,827			321,507			3,599,334
Goodwill acquired		1,138			—			1,138
Foreign currency translation		(82,537	)		—			(82,537	)

		3,196,428			321,507			3,517,935

Balance at December 31, 2011
Goodwill		3,196,428			706,507			3,902,935
Accumulated impairment losses		—			(385,000	)		(385,000	)

	$	3,196,428		$	321,507		$	3,517,935

⁽¹⁾	Goodwill acquired primarily through the acquisition of Bioniche Pharma (see Note 3).

Components Of Intangible Assets


	Weighted Average Life (Years)		Original Cost		Accumulated Amortization		Net Book Value
(In thousands)
December 31, 2011
Amortized intangible assets:
Patents and technologies		20	$	116,631	$	82,815	$	33,816
Product rights and licenses		10		3,364,263		1,418,492		1,945,771
Other⁽¹⁾		8		200,663		45,604		155,059

				3,681,557		1,546,911		2,134,646
IPR&D ⁽²⁾				496,101		—		496,101

			$	4,177,658	$	1,546,911		2,630,747

December 31, 2010
Amortized intangible assets:
Patents and technologies		20	$	122,926	$	83,563	$	39,363
Product rights and licenses		10		3,323,902		1,099,103		2,224,799
Other⁽¹⁾		8		143,716		55,171		88,545

				3,590,544		1,237,837		2,352,707
IPR&D ⁽²⁾				148,443		—		148,443

			$	3,738,987	$	1,237,837	$	2,501,150

⁽¹⁾	Other intangibles consist principally of customer lists and contracts.

⁽²⁾	See Note 3.

Product Rights And Licenses By Therapeutic Category


	December 31, 2011		December 31, 2010
(In thousands)
Allergy	$	78,557	$	120,563
Anti-infective Agents		179,386		208,537
Cardiovascular		353,026		413,296
Central Nervous System		293,106		277,835
Endocrine and Metabolic		92,482		102,113
Gastrointestinal		144,672		172,582
Respiratory Agents		331,342		367,103
Other⁽¹⁾		473,200		562,770

	$	1,945,771	$	2,224,799

⁽¹⁾	Other consists of numerous therapeutic classes, none of which individually exceeds 5% of total product rights and licenses.

- Definition

Tabular disclosure of amortizable intangibles assets, in total and by major class, including the gross carrying amount and accumulated amortization. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.

+ References+ Details

- Definition

Tabular disclosure of goodwill by reportable segment and in total. Disclosure details may include, but are not limited to, the carrying amount of goodwill, goodwill acquired during the year, goodwill impairment losses recognized, goodwill written-off due to the sale of a business unit, goodwill not yet allocated, and any other changes to goodwill.

+ References+ Details